Unveiling the Critical Gaps in Feline Diabetes Care: A Call for Innovation and Enhanced Support

The intricate landscape of feline diabetes management, often characterized by daily challenges and emotional strain for caregivers, has been brought into sharp focus through the personal testimony of Katia Colitti, whose four-year journey managing her cat Mosi’s diabetes revealed significant systemic deficiencies. Diagnosed at the age of 17, Mosi’s battle with diabetes, which concluded in 2026, underscores a pressing need for advancements in veterinary technology, clearer care protocols, and robust educational support for pet owners. Colitti’s experience, shared through the EveryCat Health Foundation, highlights three critical areas demanding immediate attention: humane and reliable glucose monitoring, improved insulin injection practices, and comprehensive, consistent veterinary guidance. These issues, while deeply personal to Colitti and Mosi, resonate with countless caregivers navigating the complexities of chronic illness in their beloved pets.

The Unseen Struggles of Feline Diabetes Management

Feline diabetes mellitus, a condition where a cat’s body either doesn’t produce enough insulin or can’t properly use the insulin it produces, affects an estimated 0.5% to 2% of the global cat population, with prevalence increasing alongside rising rates of obesity and sedentary lifestyles. It is a serious chronic disease requiring lifelong management, primarily through diet and insulin therapy. The goal of treatment is to maintain blood glucose levels within a healthy range, preventing both hyperglycemia (high blood sugar) and life-threatening hypoglycemia (low blood sugar). Achieving this delicate balance, however, is far from straightforward. The daily routine of monitoring glucose and administering insulin places a substantial burden on pet owners, often leading to burnout and significant emotional distress. Studies have shown that the perceived difficulty of managing chronic conditions like diabetes is a leading factor in treatment adherence and, in some cases, can even influence decisions regarding euthanasia, underscoring the profound need for more manageable care solutions.

The Quest for Accurate and Humane Glucose Monitoring

Perhaps the most significant hurdle in feline diabetes management, as articulated by Colitti, lies in the “excruciatingly difficult” process of glucose monitoring. Current standard practices, which involve obtaining blood samples from a cat’s ear or paw, are fraught with challenges.

• Traditional Blood Sampling: For paw sampling, the requirement for a relatively large-gauge needle often deters owners, as it can cause significant discomfort and stress to the animal. Ear sampling, while generally considered easier, is still a delicate procedure. It necessitates calming the cat, warming the ear without causing excessive bleeding, applying Vaseline to prevent blood from dispersing into fur, and precisely pricking near a vein. The subsequent race against time to get the blood drop onto a measuring strip before it clots, all while keeping a potentially distressed cat still, is a common source of frustration. Colitti’s accounts of multiple pricks, insufficient blood samples, error messages, and even accidentally causing Mosi to wince highlight the inherent trauma of this process for both cat and caregiver.
• Physical and Emotional Toll: Over time, repeated ear pricking can lead to scarring, making future attempts even harder. Mosi’s experience of severe ear damage, culminating in the necrosis and loss of an ear tip, serves as a stark and tragic reminder of the physical toll. Beyond the physical, the psychological impact on both cat and owner is profound. Cats, inherently sensitive to routine and comfort, can become fearful or resistant, transforming a necessary medical procedure into a daily battle. Owners, conversely, grapple with the guilt of causing their pet pain, often leading to tears of frustration, as Colitti candidly shared.

Limitations of Current Monitoring Technologies

The potential promise of continuous glucose monitors (CGMs), widely used in human medicine, has offered a glimmer of hope for veterinary applications. However, their off-label use in animals presents its own set of formidable obstacles. Colitti’s attempts with three human CGMs for Mosi illustrate these limitations: device activation failures, premature cessation of function well before the promised 14-day lifespan, and the invasive application and removal processes involving shaving and surgical glue. Furthermore, the small shirts often used to secure these devices can restrict a cat’s movement, particularly for older cats with pre-existing conditions like arthritis, exacerbating discomfort.

The core issue lies in the fundamental design: human CGMs are not tailored to feline body morphology, skin fragility, or activity levels. Veterinary experts agree that the thinner, more delicate skin of cats, especially elderly or frail ones, makes the application and removal of adhesive-based devices problematic. The stress associated with repeated vet visits for application and removal, coupled with device unreliability, negates the potential benefits of continuous monitoring. This situation unequivocally calls for the development of cat-specific CGMs that are smaller, lighter, gentler on fragile skin, reliable, and crucially, easy for owners to apply and remove at home.

Beyond CGMs, Colitti’s revelation about the recommended glucometer underscores another critical gap. Initially advised to use a human device, she later discovered that animal-calibrated meters might offer more accurate readings due to physiological differences in blood composition between species. The difficulty in switching due to confusing scales and instructions highlights a broader problem: managing feline diabetes should not feel like a "constant technical experiment" for dedicated caregivers. The lack of standardized, easily accessible, and species-appropriate monitoring tools adds unnecessary layers of complexity and uncertainty.

Refining Insulin Administration: A Critical Need

Insulin injection, the cornerstone of diabetes treatment, also presents unique challenges that are often overlooked in standard care guidelines.

• Injection Site Variability and Comfort: While alternating injection sites is generally recommended to prevent lipodystrophy or tissue irritation, Colitti noted that Mosi experienced discomfort in different areas, limiting their options. This highlights that "best practices" must be adaptable to individual animal needs, a nuance often missing in generic advice.
• The Problem of Thin or Frail Cats: As cats age and lose weight, particularly in their final year, administering insulin accurately becomes significantly harder. The loss of subcutaneous fat makes it difficult to create a skin tent, leading to accidental injection into the fur rather than under the skin. Standard advice rigidly warns against re-injecting to avoid life-threatening hypoglycemia, leaving owners in a terrifying dilemma when they suspect a dose wasn’t delivered. Colitti’s admission that she "probably should have taken that risk occasionally" in retrospect, but was paralyzed by fear, speaks volumes about the lack of practical, nuanced guidance for these common real-world scenarios. The drastic measure of shaving an area between Mosi’s shoulder blades became the only reliable way to ensure proper delivery, illustrating the extreme lengths owners go to in the absence of specific instruction.
• Technological Gaps in Delivery Devices: Colitti’s experience with injection pens further illuminates technological shortcomings. The loud clicking noise of a pen, while a minor inconvenience for many, proved a seizure trigger for Mosi due to an auditory disorder, immediately rendering it unusable. This specific example underscores the importance of considering a wide range of feline sensitivities and health conditions in device design. The need for quieter, feline-specific injection pens is clear, as is the development of clear, practical instructional videos and guides for injecting cats of varying body conditions, moving beyond "easy, perfect examples" to address the realities of aging, weight loss, and individual differences.

Bridging the Knowledge Gap: Veterinary Education and Support

Beyond technological solutions, the article critically examines the adequacy of veterinary guidance and education provided to caregivers. Despite Mosi receiving care at a reputable clinic, including from a diabetes specialist, Colitti frequently felt a lack of comprehensive support.

• Inconsistent and Incomplete Information: Colitti’s experience highlights several instances of inconsistent or missing information:

  • Syringe Reuse: Initial advice to reuse syringes twice, followed by later concerns about contamination and conflicting information, points to a lack of standardized, evidence-based protocols or clear communication.
  • Injection Technique: The absence of basic tips, such as holding the needle bevel-side up for smoother insertion, required independent online research, suggesting a gap in initial educational handouts.
  • Insulin Storage and Discarding: The critical detail of discarding insulin after 20 days, discovered only by deciphering tiny vial print, indicates a failure in proactive information dissemination.
  • Remission Potential: Learning too late about the possibility of diabetes remission through early, tightly regulated treatment in the first months post-diagnosis represents a significant missed opportunity, potentially impacting Mosi’s long-term prognosis and quality of life. This particular omission is critical, as studies have shown that aggressive glycemic control in the initial stages can lead to transient or even prolonged remission in a subset of newly diagnosed diabetic cats.

• The Isolation of Chronic Care: Colitti, a dedicated and proactive caregiver with resources, still felt "alone in our fight against diabetes." This sentiment is echoed by many caregivers of pets with chronic illnesses. The traditional model of periodic clinic visits, while essential, often falls short in providing the real-time, situation-specific guidance required for daily management. The implication is that veterinary practices need to evolve their support systems.

The Broader Impact: Welfare, Economics, and Innovation

The issues raised by Colitti extend far beyond a single cat and owner. They illuminate systemic challenges with profound implications for animal welfare, caregiver well-being, and the economic landscape of veterinary medicine.

• Animal Welfare: Inadequate monitoring and inconsistent insulin delivery directly impact a diabetic cat’s quality of life and health outcomes. Poorly controlled diabetes can lead to severe complications, including neuropathy, cataracts, and life-threatening ketoacidosis. The stress and pain associated with current care practices further diminish their well-being.
• Caregiver Burden: The emotional, physical, and financial toll on caregivers is immense. The constant anxiety, guilt, and frustration described by Colitti are common experiences. Financial strain from medication, supplies, and frequent veterinary visits can also be overwhelming. Enhanced support and easier management tools could significantly reduce this burden, improving treatment adherence and overall pet ownership satisfaction.
• Market Gap and Innovation: The limitations of existing products highlight a significant market gap for species-specific veterinary medical devices. While the market for human medical devices is vast and drives innovation, the veterinary market, particularly for specialized feline products, often lags due to smaller scale and perceived profitability. However, the increasing companion animal population and growing human-animal bond suggest a strong demand for sophisticated, pet-centric solutions. Investment in research and development for feline-specific CGMs, quieter injection pens, and user-friendly glucometers is not just an ethical imperative but a burgeoning economic opportunity.
• Veterinary Practice Evolution: The need for improved veterinary guidance points towards the necessity for ongoing professional development and a shift in how information is delivered. Structured follow-ups, detailed and standardized educational materials at diagnosis, and perhaps most importantly, the adoption of new communication models like video consultations or subscription-style access to veterinary nurses could revolutionize chronic illness management support. This would empower caregivers with tailored, real-time advice, fostering a stronger partnership between owners and veterinary teams.

A Call to Action for Feline Health

Katia Colitti’s heartfelt account is not merely a reflection on past struggles but a powerful call to action. Her hope is that the EveryCat Health Foundation, through its research and education funding, can spearhead the necessary improvements in feline diabetes care. The "Springing into Action" campaign in 2026, specifically directing donations to The O’Malley Fund for Diabetes and Endocrinopathies, aims to provide the critical financial support needed for ongoing diabetes studies.

Colitti, a Ukrainian-American lawyer residing in Belgium with an MSc in International Animal Welfare, Ethics, and Law, brings a unique blend of personal experience and academic insight to her advocacy. Her extensive background in animal welfare issues and deep interest in caring for geriatric and diabetic cats lend significant weight to her observations and recommendations.

The changes she describes—reliable, cat-specific monitoring devices; practical, nuanced injection guidance; and clear, comprehensive veterinary education—are not luxuries but "practical necessities." Their successful implementation would not only alleviate immense stress and suffering for diabetic cats like Mosi but also empower their caregivers, transforming a challenging daily routine into a more manageable and humane experience. By investing in these areas, the veterinary community and philanthropic organizations can collectively make a profound difference, ensuring that future generations of diabetic cats and their dedicated owners receive the best possible care. The journey with Mosi, though ended, serves as a beacon, guiding the path toward a brighter future for feline diabetes management.